COM:JANUXRX
Janux Therapeutics
- Stock
Last Close
46.50
22/11 21:00
Market Cap
2.15B
Beta: -
Volume Today
797.30K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|
average inventory | -350K - | |||||
average payables | 347.50K - | 1.44M 315.25% | 2.31M 59.98% | 2.29M 0.74% | ||
average receivables | 4M - | 4M 0% | 350K - | |||
book value per share | -1.24 - | -1.17 5.23% | 15.57 1,426.54% | 7.73 50.32% | 0.01 99.90% | |
capex per share | -0.06 - | -0.16 146.76% | -0.00 99.97% | |||
capex to depreciation | -13.12 - | -7.66 41.57% | -0.95 87.65% | |||
capex to operating cash flow | 0.09 - | 0.15 72.00% | 0.04 75.64% | |||
capex to revenue | -0.41 - | -0.75 83.66% | -0.23 69.42% | |||
cash per share | 0.10 - | 0.63 510.72% | 15.94 2,443.93% | 7.89 50.51% | 0.01 99.90% | |
days of inventory on hand | ||||||
days payables outstanding | ||||||
days sales outstanding | ||||||
debt to assets | 5.89 - | 0.05 99.21% | 0.00 98.90% | 0.07 13,510.49% | 0.06 7.20% | |
debt to equity | -0.50 - | -0.05 89.81% | 0.00 101.03% | 0.08 14,797.74% | 0.07 9.66% | |
dividend yield | ||||||
earnings yield | -0.03 - | -0.02 36.21% | -0.07 318.64% | -0.10 41.38% | -0.00 99.88% | |
enterprise value | 164.68M - | 305.87M 85.73% | 428.86M 40.21% | 520.03M 21.26% | 472.30B 90,720.99% | |
enterprise value over ebitda | -43.74 - | -46.59 6.52% | -13.02 72.05% | -7.75 40.48% | -6.65K 85,691.72% | |
ev to operating cash flow | -43.02 - | -70.01 62.74% | -25.26 63.92% | -12.12 52.04% | -9.34K 76,977.97% | |
ev to sales | 117.92 - | 60.38 48.79% | 58.43K 96,664.86% | |||
free cash flow per share | -0.60 - | -0.35 41.30% | -0.78 123.94% | -1.19 51.76% | -0.00 99.90% | |
free cash flow yield | -0.02 - | -0.01 41.30% | -0.04 185.46% | -0.09 127.35% | -0.00 99.88% | |
graham net net | -1.24 - | -1.37 10.05% | 15.36 1,224.30% | 6.84 55.46% | 0.01 99.90% | |
graham number | 4.29 - | 3.34 22.25% | 22.02 560.05% | 15.07 31.53% | 0.02 99.90% | |
income quality | 0.96 - | 0.64 32.64% | 0.52 19.32% | 0.68 31.00% | 0.87 27.46% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | |
interest coverage | -16.18 - | -23.51 45.26% | -16.64 - | |||
interest debt per share | 0.66 - | 0.08 88.37% | 0.01 89.25% | 0.71 8,480.46% | 0.00 99.92% | |
inventory turnover | ||||||
invested capital | -0.50 - | -0.05 89.81% | 0.00 101.03% | 0.08 14,797.74% | 0.07 9.66% | |
market cap | 161.34M - | 313.69M 94.42% | 464.25M 48.00% | 546.16M 17.64% | 472.29B 86,376.31% | |
net current asset value | -7.96M - | -14.79M 85.73% | 363.52M 2,557.39% | 289.17M 20.45% | 313.18M 8.30% | |
net debt to ebitda | -0.89 - | 1.19 234.07% | 1.07 9.70% | 0.39 63.77% | -0.08 119.30% | |
net income per share | -0.66 - | -0.42 36.21% | -1.38 228.42% | -1.31 5.63% | -0.00 99.90% | |
operating cash flow per share | -0.60 - | -0.35 41.30% | -0.72 105.96% | -1.04 43.46% | -0.00 99.89% | |
payables turnover | ||||||
receivables turnover | ||||||
research and ddevelopement to revenue | 7.21 - | 6.21 13.98% | 6.79 9.50% | |||
return on tangible assets | -6.24 - | -0.32 94.81% | -0.09 73.55% | -0.15 73.55% | -0.15 3.00% | |
revenue per share | 0.15 - | 0.21 34.36% | 0.00 99.91% | |||
roe | 0.53 - | 0.36 32.69% | -0.09 124.76% | -0.17 89.97% | -0.17 0.26% | |
roic | 1.01 - | 0.27 73.30% | -0.09 133.12% | -0.16 73.39% | -0.19 19.55% | |
sales general and administrative to revenue | 2.84 - | 2.58 8.98% | 3.23 25.10% | |||
shareholders equity per share | -1.24 - | -1.17 5.23% | 15.57 1,426.54% | 7.73 50.32% | 0.01 99.90% | |
stock based compensation to revenue | 1.90 - | 2.00 5.14% | 2.47 23.90% | |||
tangible asset value | -7.94M - | -14.64M 84.26% | 366.33M 2,602.58% | 320.74M 12.44% | 344.35M 7.36% | |
tangible book value per share | -1.24 - | -1.17 5.23% | 15.57 1,426.54% | 7.73 50.32% | 0.01 99.90% | |
working capital | -3.97M - | 12.88M 424.54% | 364.22M 2,727.59% | 315.93M 13.26% | 336.21M 6.42% |
All numbers in (except ratios and percentages)